NEW YORK ( TheStreet) -- Geron Corporation (Nasdaq: GERN) hit a new 52-week low Monday as it is currently trading at $2.02, below its previous 52-week low of $2.05 with 1.3 million shares traded as of 2:50 p.m. ET. Average volume has been 1.7 million shares over the past 30 days. Geron has a market cap of $283.8 million and is part of the health care sector and drugs industry. Shares are down 59.1% year to date as of the close of trading on Friday. Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes.
- Practice your GERN trading strategies and win cash in our stock game.